Publications by authors named "Aravind Velmurugan"

Claim this Profile
E
Emergence of carbapenem-resistant Typhi harboring in India: genomic evidence from a multicenter study.
Tharani Priya Thirumoorthy, Jobin John Jacob, Monisha Priya Teekaraman, S Mahantesh, Bhavana Jagannatha, Aravind Velmurugan

Front Microbiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromelioidosis outbreak in Tamil Nadu, India: an investigation of transmission with genomic insights.
Angel Miraclin Thirugnanakumar, Prabu Rajkumar, Karthik Gunasekaran, Pavithra Mannam, Manickam Ponnaiah, Aravind Velmurugan

Lancet Reg Health Southeast Asia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent emergence of cephalosporin-resistant Typhi in India due to the endemic clone acquiring IncFIB(K) plasmid encoding gene.
Tharani Priya Thirumoorthy, Jobin John Jacob, Aravind Velmurugan, Monisha Priya Teekaraman, Bhavini Shah

Microbiol Spectr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel β-lactam/β-lactamase inhibitor combinations show limited activity against Indian carbapenem-resistant Pseudomonas aeruginosa isolates due to conundrum of diverse resistance mechanisms.
Prashant R Joshi, Smita Dharmadhikar Joshi, Hariharan Periasamy, Yamuna Devi Bakthavatchalam, Aravind Velmurugan

Int J Antimicrob Agents· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal population genomics changes during the early time period of conjugate vaccine uptake in southern India.
Iftekhar M Rafiqullah, Rosemol Varghese, K Taylor Hellmann, Aravind Velmurugan, Ayyanraj Neeravi

Microb Genom· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report.
Dilip Dubey, Manish Roy, Tajamul H Shah, Noor Bano, Vidushi Kulshrestha, Aravind Velmurugan

Ann Clin Microbiol Antimicrob· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic analysis unveils genome degradation events and gene flux in the emergence and persistence of S. Paratyphi A lineages.
Jobin John Jacob, Agila K Pragasam, Karthick Vasudevan, Aravind Velmurugan, Monisha Priya Teekaraman

PLoS Pathog· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis